Molecular characterization of allergens and component-resolved diagnosis of IgE-mediated mango fruit allergy

TY - JOUR

T1 - Molecular characterization of allergens and component-resolved diagnosis of IgE-mediated mango fruit allergy

AU - Zhao, Lan

AU - Xie, Hanbing

AU - Wang, Xuefeng

AU - Liu, Meiling

AU - Ma, Tingting

AU - Fu, Wanyi

AU - Wang, Yuqi

AU - Wu, Dongya

AU - Feng, Yan

AU - Liu, Yi

AU - Wu, Shandong

AU - Zhang, Xianqi

AU - Wang, Huiying

AU - Luo, Fangmei

AU - Guo, Baohua

AU - Wu, Hongxia

AU - Yu, Yongmei

AU - Fu, Linglin

AU - Valenta, Rudolf

AU - Vrtala, Susanne

AU - van Ree, Ronald

AU - Wang, Xueyan

AU - Gao, Zhongshan

N1 - Funding Information: We thank Professor Richard E. Goodman, Chairman of the Executive Committee of the WHO/IUIS Allergen Nomenclature Sub-committee, and the committee members for evaluating and including the new allergens reported in this paper. We thank Yang Zhaowei, Hu Chaoyi, Hu Zhangjian, and Dr. Wu Lingying for their assistance with serum collection and testing. We thank Professor Guo Yirong for providing the cell culture facilities and assistance. We thank Ma Cheng from the Core Facilities, Zhejiang University School of Medicine for his technical support. This study was carried out with financial support by the National Natural Science Foundation of China (31772271), National Key R&D Program of China-Austria Scientific Cooperation (2019YFE0106600 and CN 14/2020), Wujieping Medical Foundation (320.6750.2022-02-29), and in part by the DANUBE ARC research program of the Country of Lower Austria. Funding Information: We thank Professor Richard E. Goodman, Chairman of the Executive Committee of the WHO/IUIS Allergen Nomenclature Sub‐committee, and the committee members for evaluating and including the new allergens reported in this paper. We thank Yang Zhaowei, Hu Chaoyi, Hu Zhangjian, and Dr. Wu Lingying for their assistance with serum collection and testing. We thank Professor Guo Yirong for providing the cell culture facilities and assistance. We thank Ma Cheng from the Core Facilities, Zhejiang University School of Medicine for his technical support. This study was carried out with financial support by the National Natural Science Foundation of China (31772271), National Key R&D Program of China‐Austria Scientific Cooperation (2019YFE0106600 and CN 14/2020), Wujieping Medical Foundation (320.6750.2022‐02‐29), and in part by the DANUBE ARC research program of the Country of Lower Austria. Funding Information: Gao ZS, Liu Y, and Feng Y received funds from the Ministry of Science and Technology of China (2019YFE0106600). Susanne Vrtala received funds from the Austrian government (CN 14/2020). Tingting Ma received fund from the Wujieping Foundation China (320.6750.2022‐02‐29). Rudolf Valenta has received research grants from Worg Pharmaceuticals, Hangzhou, China, HVD Biotech, Vienna, Austria and Viravaxx AG, Vienna, Austria. He serves as consultant for Viravaxx and Worg. Ronald van Ree reports consultancies for HAL Allergy BV, Citeq BV, Angany Inc., Reacta Healthcare Ltd., Mission MightyMe, and AB Enzymes; speaker's fees from HAL Allergy BV, ALK, and Thermo Fisher Scientific; stock options from Angany Inc. All other authors declare no conflicts of interest in relation to this work. Patent applications are pending for Man i 1 (202210254140.6), Man i 2 (202210112736.2), and Man i 4 (202210255709.0) in China.

PY - 2023/6

Y1 - 2023/6

UR - http://www.scopus.com/inward/record.url?scp=85147932761&partnerID=8YFLogxK

U2 - 10.1111/all.15664

DO - 10.1111/all.15664

M3 - Letter/short communication

C2 - 36724175

SN - 0105-4538

VL - 78

SP - 1699

EP - 1703

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

IS - 6

ER -